Weekly integral dose and use of lipid lowering drugs are associated with worsening of functional outcomes in prostate cancer patients treated with IMRT.
Authors
Cicchetti, ARancati, T
Joseph, N
Chang-Claude, J
Giandini, T
Fiorino, C
Cozzarini, C
Palorini, F
Morlino, S
Davidson, Susan E
Johnson, K
Talbot, C
Webb, A
McWilliam, Alan
West, Catharine M L
Valdagni, R
Choudhury, Ananya
Affiliation
Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, ItalyIssue Date
2017-10
Metadata
Show full item recordCitation
Weekly integral dose and use of lipid lowering drugs are associated with worsening of functional outcomes in prostate cancer patients treated with IMRT. 2017, 99(2): S182 Int J Radiat Oncol Biol PhysJournal
International Journal of Radiation Oncology*Biology*PhysicsDOI
10.1016/j.ijrobp.2017.06.456Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0360301617315080Type
Meetings and ProceedingsLanguage
enISSN
03603016ae974a485f413a2113503eed53cd6c53
10.1016/j.ijrobp.2017.06.456